The Multicenter Study for Effects of Eplerenone on Cardiac Diastolic Dysfunction in Hypertensive Patients
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 05 Apr 2017
At a glance
- Drugs Eplerenone (Primary)
- Indications Diastolic heart failure; Hypertension
- Focus Biomarker; Pharmacodynamics
- Acronyms MELODY
- 03 Apr 2017 Planned End Date changed from 1 Jan 2015 to 30 Jun 2017.
- 27 Mar 2016 Status changed from recruiting to active, no longer recruiting.
- 09 Oct 2013 Planned number of patients changed from 400 to 180 as reported by University Hospital Medical Information Network - Japan.